Chargement en cours...
KRAS mutation testing in metastatic colorectal cancer
The KRAS oncogene is mutated in approximately 35%-45% of colorectal cancers, and KRAS mutational status testing has been highlighted in recent years. The most frequent mutations in this gene, point substitutions in codons 12 and 13, were validated as negative predictors of response to anti-epidermal...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Co., Limited
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3468848/ https://ncbi.nlm.nih.gov/pubmed/23066310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i37.5171 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|